Equity Analysis

Quarterly Results

    Kobo Biotech Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    531541
    INE881A01015
    -55.7880378
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    6.6
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsJun 2024Mar 2024Dec 2023
Gross Sales0.000.000.00
Other Operating Income0.000.000.00
Other Income 0.020.000.00
Total Income0.020.000.00
Total Expenditure 0.340.250.20
PBIDT-0.32-0.25-0.20
Interest 0.000.000.00
PBDT-0.32-0.25-0.20
Depreciation1.011.011.03
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax-1.33-1.26-1.23
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-1.33-1.26-1.23
EPS (Unit Curr.)-0.56-0.53-0.52
EPS (Adj) (Unit Curr.)-0.56-0.53-0.52
Calculated EPS (Unit Curr.)-0.56-0.53-0.52
Calculated EPS (Adj) (Unit Curr.)-0.56-0.53-0.52
Calculated EPS (Ann.) (Unit Curr.)-2.23-2.11-2.07
Calculated EPS (Adj) (Ann.) (Unit Curr.)-2.23-2.11-2.07
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity23.8323.8323.83
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)0.000.000.00
PBDTM(%)0.000.000.00
PATM(%)0.000.000.00
Dividend Per Share(Rs)0.000.000.00
Diluted EPS-0.56-0.53-0.52